European Survey of Cardiovascular Disease Prevention, Diabetes and Chronic Kidney Disease (EUROASPIRE VI)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorEuropean Society of Cardiology

About this trial

The goal of this observational study is to provide a unique European picture of preventive action by cardiologists, other specialists and primary care physicians looking after patients with coronary heart disease (CHD), individuals at high cardiovascular disease risk and all those with hypertension, dyslipidaemia (including familial hypercholesterolaemia), diabetes and dysglycaemia and chronic kidney disease (CKD) and determine whether the European guidelines on cardiovascular disease prevention, hypertension, lipids, diabetes and chronic kidney disease are being followed.

Eligibility criteria

Qualifiers

Patients having signed an informed Consent

Patients aged from 18 years old at the time of identification

At least six and at most 24 months elapsed between the index event (the recruiting diagnostic or treatment criteria below) and the date of interview

Coronary patients: Acute coronary events (acute coronary syndrome {STEMI or NSTEMI}, unstable angina) or an emergency or elective revascularisation for coronary artery disease (CABG, PCI)

Disqualifiers

Patients living outside defined geographical areas

Patients admitted to hospital from outside the geographical area or under the care of cardiologists in hospitals that do not participate in EUROASPIRE VI

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

8,000 Participants
are grouped into 2 trial groups

Sponsors and collaborators

European Society of Cardiology

Lead sponsor

National Institute for Prevention and Cardiovascular Health, Ireland

Collaborator